Search research articles
Contact Us
Filters
Showing results (1401-1410 of 1,669) with videos related to
Page
of 167
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1990
Intraperitoneal lymphokine-activated killer-cell and interleukin-2 therapy for malignancies limited to the peritoneal cavity
R G Steis, W J Urba, L A VanderMolen, et al.
Plos One
|
August 1, 2012
Genome-wide histone acetylation is altered in a transgenic mouse model of Huntington's disease
Karen N McFarland, Sudeshna Das, Ting Ting Sun, et al.
Journal of Biomechanics
|
March 29, 2023
Functional range of motion of the cervical spine in cervical fusion patients during activities of daily living
Michelle Riffitts, Adrianna Oh, Abenezer Alemu, et al.
Environmental Science & Technology
|
September 17, 2024
Impacts on Atlantic Killifish from Neurotoxicants: Genes, Behavior, and Population-Relevant Outcomes
Janice L Albers, Lori N Ivan, Bryan W Clark, et al.
Clinics in Dermatology
|
January 7, 2024
Novel B-DNA dermatophyte assay for demonstration of canonical DNA in dermatophytes: Histopathologic characterization by artificial intelligence
Claude E Gagna, Anthony N Yodice, Juliana D'Amico, et al.
Plos Genetics
|
March 8, 2013
MSH3 polymorphisms and protein levels affect CAG repeat instability in Huntington's disease mice
Stéphanie Tomé, Kevin Manley, Jodie P Simard, et al.
ACS Macro Letters
|
May 24, 2022
Chemical and Electrochemical Manipulation of Mechanical Properties in Stimuli-Responsive Copper-Cross-Linked Hydrogels
Rachel D Harris, Jeffrey T Auletta, S Amin Mohaghegh Motlagh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 3, 2008
Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancer
Brian M Wolpin, Aram F Hezel, Thomas Abrams, et al.
ACS Nano
|
December 20, 2022
Fluorous-Directed Assembly of DNA Origami Nanostructures
Jiajia Zou, Ashley C Stammers, Andrea Taladriz-Sender, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 31, 2014
Clinical benefit of continuing ALK inhibition with crizotinib beyond initial disease progression in patients with advanced ALK-positive NSCLC
S-H I Ou, P A Jänne, C H Bartlett, et al.
Page
of 167
Search research articles
Search
Showing results (1401-1410 of 1,669) with videos related to
Sort By:
Page
of 167
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1990
Intraperitoneal lymphokine-activated killer-cell and interleukin-2 therapy for malignancies limited to the peritoneal cavity
R G Steis, W J Urba, L A VanderMolen, et al.
Plos One
|
August 1, 2012
Genome-wide histone acetylation is altered in a transgenic mouse model of Huntington's disease
Karen N McFarland, Sudeshna Das, Ting Ting Sun, et al.
Journal of Biomechanics
|
March 29, 2023
Functional range of motion of the cervical spine in cervical fusion patients during activities of daily living
Michelle Riffitts, Adrianna Oh, Abenezer Alemu, et al.
Environmental Science & Technology
|
September 17, 2024
Impacts on Atlantic Killifish from Neurotoxicants: Genes, Behavior, and Population-Relevant Outcomes
Janice L Albers, Lori N Ivan, Bryan W Clark, et al.
Clinics in Dermatology
|
January 7, 2024
Novel B-DNA dermatophyte assay for demonstration of canonical DNA in dermatophytes: Histopathologic characterization by artificial intelligence
Claude E Gagna, Anthony N Yodice, Juliana D'Amico, et al.
Plos Genetics
|
March 8, 2013
MSH3 polymorphisms and protein levels affect CAG repeat instability in Huntington's disease mice
Stéphanie Tomé, Kevin Manley, Jodie P Simard, et al.
ACS Macro Letters
|
May 24, 2022
Chemical and Electrochemical Manipulation of Mechanical Properties in Stimuli-Responsive Copper-Cross-Linked Hydrogels
Rachel D Harris, Jeffrey T Auletta, S Amin Mohaghegh Motlagh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 3, 2008
Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancer
Brian M Wolpin, Aram F Hezel, Thomas Abrams, et al.
ACS Nano
|
December 20, 2022
Fluorous-Directed Assembly of DNA Origami Nanostructures
Jiajia Zou, Ashley C Stammers, Andrea Taladriz-Sender, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 31, 2014
Clinical benefit of continuing ALK inhibition with crizotinib beyond initial disease progression in patients with advanced ALK-positive NSCLC
S-H I Ou, P A Jänne, C H Bartlett, et al.
Page
of 167